The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma

<div>Survival data presentation. Information about the accumulating DFS (a) and accumulating OS (b) in the studied patients.</div>

Journal of Clinical Pharmacy and Therapeutics

fig1

Figure 1

Figure 1: The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma 

Figure 1 | The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma 